The Brand Name FLOVAS Has Generic Salt :: PITAVASTATIN 

FLOVAS  Is From Company Ipca Priced :: Rs. 90

FLOVAS have PITAVASTATIN is comes under Sub class Anti Hyperlipidemics of  Main Class Cardiovascular System

Main Medicine Class:: Cardiovascular System  Sub Medicine Class :: Anti Hyperlipidemics 

 Salt Name :  OR Generic Name Form Price : MRP /Probable Packing
Brand Name Company / Manufacturers Strength Unit Price / 10
 FLOVAS  Ipca  1MG  10 Rs. 90

Company  Brand Name  Salt Combination Main Medical Class Sub Medical Class
 From Ipca :: FLOVAS  PITAVASTATIN  Cardiovascular System Anti Hyperlipidemics

Indications for Drugs ::

Cardiovascular disease, Hypercholesterolaemia

Drug Dose ::

The dose range for Pitavastatin is 1 to 4 mg orally once daily at any time of the day with or without food. The recommended starting dose is 2 mg and the maximum dose is 4 mg. The starting dose and maintenance doses of Pitavastatin should be individualized according to patient characteristics, such as goal of therapy and response.

Contraindication ::

Patients with a known hypersensitivity to any component of this products. Pitavastatin is contraindicated in patients with active liver disease , which may include unexplained persistent elevations of hepatic transaminase levels.

Drug Precautions ::

Use with caution in clients with predisposing factors to myopathy (e.g., >65 years of age, renal impairment, inadequately treated hypothyroidism) and in clients with impaired renal function, the elderly, or when used together with fibrates or lipid-modifying doses of niacin. ? Elderly clients may manifest greater sensitivity to pitavastatin. ? Safety and efficacy not determined in children.

Drug Side Effects ::

Pitavastatin is generally well tolerated . The common side effects are headache , myalgia , asthenia , constipation , dizziness , and abdominal pain. It may rarely cause rhabdomyolysis and hypersensitivity reaction , such as-rash , pruritus and urticaria.

Pregnancy category ::
Pregnancy category


Drug Mode of Action ::  

HMG-CoA reductase inhibitor, inhibits rate-limiting step in cholesterol biosynthesis by competitively inhibiting HMG-CoA reductase

Drug Interactions ::

Increased bioavailability w/ erythromycin and rifampicin. Increased risk of myopathy/rhabdomyolysis w/ gemfibrozil, colchicine, niacin and other fibrates. Potentially Fatal: Ciclosporin significantly increases pitavastatin exposure.


Disclaimer ::

The Information available on this site is for only Informational Purpose , before any use of this information please consult your Doctor .Price of the drugs indicated above may not match to real price due to many possible reasons may , including local taxes etc.. These are only approximate indicative prices of the drug.


One of the 1st in India.High Quality Generic Medicine Portal Android Application for Online Oreder & Information.

For More Join Our Membership and Get Additional 25% off on Meds, also get MLM Benefits to get a permanent earning source.

Join Membership How to Search Medicine
Android App

We would like to keep you updated with special notifications.